{
  "created_at": "2021-09-17T01:06:18.811Z",
  "title": "Where is the scrutiny over FDA’s role in the overdose epidemic?",
  "url": "https://www.inquirer.com/opinion/commentary/opioids-accountability-fda-janet-woodcock-20210914.html",
  "author": "colinprince",
  "points": 146,
  "num_comments": 103,
  "_tags": [
    "story",
    "author_colinprince",
    "story_28547864"
  ],
  "objectID": "28547864",
  "original_created_at": "2021-09-16T04:05:00.000Z",
  "image": "https://www.inquirer.com/resizer/bSpZEdFNE8zoWhO8YvatopTRS2k=/2x0:3000x2000/760x507/filters:format(webp)/cloudfront-us-east-1.images.arcpublishing.com/pmn/CRSYKFPK6JDGZJDY3HMEWIS6LA.jpg",
  "localize": [
    {
      "locale": "ja",
      "title": "過剰摂取の蔓延に対するFDAの役割については、どこで精査されているのでしょうか？"
    },
    {
      "locale": "zh",
      "title": "对FDA在药物过量流行中的作用的审查在哪里？"
    },
    {
      "locale": "zh-Hant",
      "title": "對FDA在藥物過量流行中的作用的審查在哪裏？"
    }
  ],
  "source_updated_at": 1632476406362
}